CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy

Alves, Wilson Eduardo Furlan Matos; Bonatelli, Murilo; Dufloth, Rozany; Kerr, Lígia Maria; Carrara, Guilherme Freire Angotti; da Costa, Ricardo Filipe Alves; Scapulatempo-Neto, Cristovam; Tiezzi, Daniel; da Costa Vieira, René Aloísio; Pinheiro, Céline

doi:10.1186/s12885-019-6353-2

BMC Cancer

Article metrics
Last updated: Thu, 25 Apr 2024 10:18:33 Z

CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy

Access & Citations

2755

Article Accesses
11

Web of Science
13

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1471-2407

Contact us

Submission enquiries: bmccancer@biomedcentral.com
General enquiries: ORSupport@springernature.com